A UK-based clinical trial explored the impact of twice-daily Montmorency tart cherry juice supplementation on patients with mild to moderate ulcerative colitis. The study revealed significant improvements in quality-of-life scores and reductions in disease activity markers among participants consuming tart cherry juice compared with placebo. These findings suggest that tart cherry supplementation may play a complementary role in the management of ulcerative colitis, potentially offering clinical benefits for patients.